Hematologic Malignancies   

What would be your RT volumes and dose?

If so, what dose and fractionation would you recommend?

Patient was previously well controlled on methotrexate, which was discontinued during cancer treatment.

In this scenario, is systemic treatment better given bilateral involvement? In a patient who has already had cataract surgery and is not at risk for c...